RCC2P4

Across TCGA pan-cancer cohorts, RCC2P4 RNA differs between tumor and matched normal tissue in 2 of 18 cancer types tested, making tumor–normal expression one of RCC2P4’s most consistent transcriptional readouts.

The strongest signal is observed in colon adenocarcinoma (COAD), where RCC2P4 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RCC2P4 is over-expressed in tumor.

COAD and STAD are the cancer types where RCC2P4 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RCC2P4 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
COAD	All	All	+0.070	.007	4	view →
STAD	All	All	+0.104	.003	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 2 strongest of 2 lineages.

RCC2P4–COAD

Open the COAD breakdown →